Tumor patients without or under therapy are suggested to be immunologically compromised. - How can "immunocompetence" of these patients be defined? - Which surface markers on lymphocytes (measurable by FACS) can describe immuno(in)competence? - Normal ranges/references Prof. Dr. Harald Schlebusch UFK Tübingen
This archive was generated by hypermail 2b29 : Sat Mar 10 2001 - 19:31:33 EST